As a seasoned medical marketer with years of experience in PR, I’ve come to understand a simple yet heavy truth: every campaign we run has the potential to directly or indirectly impact people’s health. But there’s another, less obvious realization: we are not just responsible for how we promote a product, but also for how it affects the fair and ethical use of resources.
Take, for example, the recent “hype” around drugs like Ozempic. Their explosion in popularity across social media has driven massive interest among people using them for purposes outside their original medical indication. And yes, we, as marketers, have played a role in this: clever messaging, glossy visuals, success stories, and the promise of “dream results.”
But have we paused to think about what’s happening beyond our metrics and sales figures? About the fact that every pen used to chase a trend could have been life-changing for a diabetic patient who needs it as a necessity, not a luxury?
Marketing in medicine isn’t just about driving revenue; it’s about balance. It’s about remembering that behind every “successful campaign” lies someone’s health, life, or hope. It’s about understanding that popularizing a drug for aesthetic or trend-driven reasons can transform a medical solution into a product that’s accessible only to those who can afford it, not to those who truly need it.
We must ask ourselves the tough questions:
These are uncomfortable questions, but they’re the ones that make us professionals. I believe that smart, effective medical marketing can be both successful and ethical. But to achieve that, we need to remind ourselves that healthcare advertising isn’t just about “persuasion”; it’s about “doing no harm.”
💬 What are your thoughts? Where do you see the line between effective promotion and ethical boundaries? How do you feel about current trends in the use of medical treatments?
Error: Contact form not found.
By clicking on the button, you agree to the privacy policy